Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Materialise NV is a Belgium-based additive manufacturing company that develops 3D printing software, provides 3D printing services, and produces customized medical devices. The company operates across the additive manufacturing, healthcare technology, and industrial manufacturing industries, with revenue primarily driven by software licensing, medical solutions, and on-demand manufacturing services. Its core customers include hospitals and medical device companies, industrial manufacturers, automotive and aerospace firms, and research institutions.
Founded in 1990, Materialise NV is widely recognized for its early and sustained focus on software as the backbone of industrial-scale 3D printing. The company has established a differentiated position through its vendor-neutral software platforms that integrate with a wide range of 3D printers and materials. Over time, Materialise evolved from a rapid prototyping service provider into a global additive manufacturing leader, culminating in its public listing on the NASDAQ in 2014 under the ticker MTLS.
Business Operations
Materialise operates through three primary business segments: Software, Medical, and Manufacturing. The Software segment includes flagship platforms such as Materialise Magics and Mimics, which enable design optimization, build preparation, and medical image-based modeling for additive manufacturing workflows. This segment generates recurring revenue through licenses and maintenance contracts and serves industrial and healthcare customers globally.
The Medical segment focuses on Materialise Medical, which provides FDA-cleared and CE-marked software, patient-specific surgical guides, and 3D-printed implants for orthopedic, cranio-maxillofacial, and cardiovascular applications. The Manufacturing segment delivers on-demand 3D printing and rapid prototyping services across multiple technologies and materials. Materialise operates production facilities in Europe, North America, and Asia, supporting both domestic and international customers through centralized and regional manufacturing hubs.
Strategic Position & Investments
Materialise’s strategy emphasizes long-term growth through software innovation, regulated medical solutions, and scalable manufacturing services. The company continues to invest in cloud-enabled platforms, automation, and data-driven additive manufacturing workflows to reinforce its role as an infrastructure provider for the 3D printing ecosystem. Its vendor-neutral approach allows it to partner with a broad range of hardware manufacturers rather than compete directly with them.
Notable acquisitions include Link3D, which expanded Materialise’s capabilities in additive manufacturing execution systems, and Engimplan, a Brazil-based orthopedic implant manufacturer that strengthened its medical device portfolio and presence in Latin America. Materialise also maintains strategic collaborations with major industrial and healthcare partners to support adoption of additive manufacturing in regulated and production environments.
Geographic Footprint
Materialise is headquartered in Leuven, Belgium, and maintains operations across Europe, North America, Asia-Pacific, and Latin America. The company operates production and development facilities in Belgium, the United States, Germany, and China, among other locations, supporting a globally diversified customer base.
International markets account for a significant portion of revenue, with strong demand from North America and Europe in both industrial and medical applications. Through subsidiaries and local offices, Materialise supports multinational customers and healthcare institutions while complying with regional regulatory requirements for medical software and devices.
Leadership & Governance
Materialise is led by its founder, whose long-term vision emphasizes sustainable growth, software-driven differentiation, and responsible innovation in additive manufacturing. The company operates under a dual-class share structure that preserves strategic continuity while maintaining public market access.
Key executives include:
- Fried Vancraen – Founder and Chief Executive Officer
- Stefaan Motte – Chief Financial Officer
- Bart Van der Schueren – Chief Technology Officer
The leadership team combines technical expertise, regulatory experience, and long-term strategic focus, with governance practices aligned to its public company status and international operations.